HHRI News & Press Releases
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read MoreHennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read MoreProtected: Immune Therapy and Immunology
There is no excerpt because this is a protected post.
Read MoreHennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read MoreHennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More